This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Data availability
The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Martelli MP, Sportoletti P, Tiacci E, Martelli MF, Falini B. Mutational landscape of AML with normal cytogenetics: biological and clinical implications. Blood Rev. 2013;27:13–22.
Prada-Arismendy J, Arroyave JC, Röthlisberger S. Molecular biomarkers in acute myeloid leukemia. Blood Rev. 2017;31:63–76.
Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N. Engl J Med. 2016;374:2209–21.
Mahtab M, Boavida A, Santos D, Pisani FM. The genome stability maintenance DNA helicase DDX11 and its role in cancer. Genes. 2021;12:395.
Pisani FM, Napolitano E, Napolitano LMR, Onesti S. Molecular and cellular functions of the Warsaw breakage syndrome DNA helicase DDX11. Genes. 2018;9:564.
Zhang T, Auer P, Dong J, Cutler C, Dezern AE, Gadalla SM, et al. Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study. J Hematol Oncol. 2023;16:37.
Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405.
Zhou YL, Wu LX, Peter Gale R, Wang ZL, Li JL, Jiang H, et al. Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms-like tyrosine kinase three internal tandem duplication (FLT3-ITD). Br J Haematol. 2020;190:274–83.
Döhner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345–77.
Trottier AM, Godley LA. Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities. Br J Haematol. 2021;194:663–76.
Cheah JJC, Hahn CN, Hiwase DK, Scott HS, Brown AL. Myeloid neoplasms with germline DDX41 mutation. Int J Hematol. 2017;106:163–74.
Polprasert C, Schulze I, Sekeres MA, Makishima H, Przychodzen B, Hosono N, et al. Inherited and somatic defects in DDX41 in myeloid neoplasms. Cancer Cell. 2015;27:658–70.
Brosh RM Jr. DNA helicases involved in DNA repair and their roles in cancer. Nat Rev Cancer. 2013;13:542–58.
Acknowledgements
RPG acknowledges support from the National Institute of Health Research (NIHR) Biomedical Research.
Funding
Supported by grants from National Natural Science Foundation of China [Grant 82100169], National Natural Science Foundation of China [Grant 81930004], Major Programme of the National Natural Science Foundation of China [Grant 82293630], National Key Research and Development Program of China [No. 2022YFA1103300] and the Beijing Municipal Natural Science Foundation [Grant 7192213].
Author information
Authors and Affiliations
Contributions
G-RR, X-JH and RPG designed the project and prepared the typescript. Y-LZ, M-YZ, S-BC, FL, L-XL and J-YQ performed the experiments and statistical analyses. HJ, QJ, L-PX, and X-HZ provided clinical data. All authors read and approved the final typescript and agreed to submit it for publication.
Corresponding authors
Ethics declarations
Competing interests
RPG is a consultant to Antengene Biotech LLC; Medical Director, FFF Enterprises Inc.; A speaker for Janssen Pharma and Hengrui Pharma; Board of Directors: Russian Foundation for Cancer Research Support and Scientific Advisory Board, StemRad Ltd.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Zhou, YL., Zhao, MY., Gale, R.P. et al. Mutations in DEAD/H-box helicase 11 correlate with increased relapse risk in adults with acute myeloid leukaemia with normal cytogenetics. Leukemia 38, 223–225 (2024). https://doi.org/10.1038/s41375-023-02085-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41375-023-02085-7